Volume 26, Number 1—January 2020
Dispatch
Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales
Figure 1

Figure 1. Estimated incidence of adverse health outcomes resulting from antibiotic-resistant infections, plotted against the overall antibiotic consumption in primary care settings in 30 countries in Europe, 2015. A) Antibiotic-resistant cases/1,000 person-years; B) attributable DALYs/1,000 person-years; C) attributable deaths/1,000 person-years. Red circles indicate datapoints for the United Kingdom; error bars indicate 95% CIs. Blue lines indicate linear regressions; gray shading indicates 95% confidence regions for linear regressions. DALYs, disability-adjusted life years; DDD, defined daily dose.
1These authors contributed equally to this article.
Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.